These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
345 related articles for article (PubMed ID: 28356570)
41. Lung fibrosis-associated soluble mediators and bronchoalveolar lavage from idiopathic pulmonary fibrosis patients promote the expression of fibrogenic factors in subepithelial lung myofibroblasts. Bouros E; Filidou E; Arvanitidis K; Mikroulis D; Steiropoulos P; Bamias G; Bouros D; Kolios G Pulm Pharmacol Ther; 2017 Oct; 46():78-87. PubMed ID: 28865842 [TBL] [Abstract][Full Text] [Related]
42. Global impairment of CD4+CD25+FOXP3+ regulatory T cells in idiopathic pulmonary fibrosis. Kotsianidis I; Nakou E; Bouchliou I; Tzouvelekis A; Spanoudakis E; Steiropoulos P; Sotiriou I; Aidinis V; Margaritis D; Tsatalas C; Bouros D Am J Respir Crit Care Med; 2009 Jun; 179(12):1121-30. PubMed ID: 19342412 [TBL] [Abstract][Full Text] [Related]
43. Mesenchymal stem cells and idiopathic pulmonary fibrosis. Potential for clinical testing. Toonkel RL; Hare JM; Matthay MA; Glassberg MK Am J Respir Crit Care Med; 2013 Jul; 188(2):133-40. PubMed ID: 23306542 [TBL] [Abstract][Full Text] [Related]
44. Advances in the treatment of idiopathic pulmonary fibrosis. Sergew A; Brown KK Expert Opin Emerg Drugs; 2015; 20(4):537-52. PubMed ID: 26629731 [TBL] [Abstract][Full Text] [Related]
45. Increased levels of free circulating DNA in patients with idiopathic pulmonary fibrosis. Casoni GL; Ulivi P; Mercatali L; Chilosi M; Tomassetti S; Romagnoli M; Ravaglia C; Gurioli C; Gurioli C; Zoli W; Silvestrini R; Poletti V Int J Biol Markers; 2010; 25(4):229-35. PubMed ID: 21161945 [TBL] [Abstract][Full Text] [Related]
46. Idiopathic pulmonary fibrosis: current treatment options and critical appraisal of nintedanib. Bonella F; Stowasser S; Wollin L Drug Des Devel Ther; 2015; 9():6407-19. PubMed ID: 26715838 [TBL] [Abstract][Full Text] [Related]
47. Usual interstitial pneumonia end-stage features from explants with radiologic and pathological correlations. Rabeyrin M; Thivolet F; Ferretti GR; Chalabreysse L; Jankowski A; Cottin V; Pison C; Cordier JF; Lantuejoul S Ann Diagn Pathol; 2015 Aug; 19(4):269-76. PubMed ID: 26025258 [TBL] [Abstract][Full Text] [Related]
48. Idiopathic pulmonary fibrosis with emphysema: evidence of synergy among emphysema and idiopathic pulmonary fibrosis in smokers. Mitchell PD; Das JP; Murphy DJ; Keane MP; Donnelly SC; Dodd JD; Butler MW Respir Care; 2015 Feb; 60(2):259-68. PubMed ID: 25389350 [TBL] [Abstract][Full Text] [Related]
49. Pathogenesis of idiopathic pulmonary fibrosis: from initial apoptosis of epithelial cells to lung remodeling? Jin HL; Dong JC Chin Med J (Engl); 2011 Dec; 124(24):4330-8. PubMed ID: 22340409 [TBL] [Abstract][Full Text] [Related]
50. Macrophages: friend or foe in idiopathic pulmonary fibrosis? Zhang L; Wang Y; Wu G; Xiong W; Gu W; Wang CY Respir Res; 2018 Sep; 19(1):170. PubMed ID: 30189872 [TBL] [Abstract][Full Text] [Related]
51. Gremlin-1 Overexpression in Mouse Lung Reduces Silica-Induced Lymphocyte Recruitment - A Link to Idiopathic Pulmonary Fibrosis through Negative Correlation with CXCL10 Chemokine. Koli K; Sutinen E; Rönty M; Rantakari P; Fortino V; Pulkkinen V; Greco D; Sipilä P; Myllärniemi M PLoS One; 2016; 11(7):e0159010. PubMed ID: 27428020 [TBL] [Abstract][Full Text] [Related]
52. Angiostatic versus angiogenic chemokines in IPF and EAA. Martina S; Martina V; Monika M; Jan P; Libor K; Ilja S Respir Med; 2009 Nov; 103(11):1651-6. PubMed ID: 19535235 [TBL] [Abstract][Full Text] [Related]
58. Serum metalloproteinases 1 and 7 in the diagnosis of idiopathic pulmonary fibrosis and other interstitial pneumonias. Morais A; Beltrão M; Sokhatska O; Costa D; Melo N; Mota P; Marques A; Delgado L Respir Med; 2015 Aug; 109(8):1063-8. PubMed ID: 26174192 [TBL] [Abstract][Full Text] [Related]